MorphoMorpho,Inc.3653東証グロース情報・通信業FY ending Oct 2025, consolidated, J-GAAP

Morpho revenue and profit

Out of every ¥100 of sales, about ¥1 is left as operating profit. Revenue changed +1.8% from the prior year, operating profit -82.2%.

Five-year trend

Revenue¥3.36B
FY ending Oct 2021: ¥1.73B¥1.73BFY ending Oct 2022: ¥2B¥2BFY ending Oct 2023: ¥2.38B¥2.38BFY ending Oct 2024: ¥3.3B¥3.3BFY ending Oct 2025: ¥3.36B¥3.36BFY21FY22FY23FY24FY25
Operating income¥45.8M
FY ending Oct 2021: -¥881.6M-¥881.6MFY ending Oct 2022: -¥588.4M-¥588.4MFY ending Oct 2023: -¥244.4M-¥244.4MFY ending Oct 2024: ¥257.1M¥257.1MFY ending Oct 2025: ¥45.8M¥45.8MFY21FY22FY23FY24FY25
Operating margin1.4%
FY ending Oct 2021: -50.9%-50.9%FY ending Oct 2022: -29.5%-29.5%FY ending Oct 2023: -10.3%-10.3%FY ending Oct 2024: 7.8%7.8%FY ending Oct 2025: 1.4%1.4%FY21FY22FY23FY24FY25

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin—
2024: 9.1%9.1%2122232425
Asset turnover—
2024: 0.83×0.83×2122232425
ROA-1.8%
2021: -17.4%-17.4%2022: -15.9%-15.9%2023: -7.9%-7.9%2024: 7.6%7.6%2025: -1.8%-1.8%2122232425
Financial leverage—
2024: 1.22×1.22×2122232425
ROE—
2024: 9.2%9.2%2122232425
PeriodNet marginAsset turnoverROAFinancial leverageROE
2021——×-17.4%—×—
2022——×-15.9%—×—
2023——×-7.9%—×—
20249.1%0.83×7.6%1.22×9.2%
2025——×-1.8%—×—

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue2.0%
2020: 7.1%7.1%2021: 7.3%7.3%2022: 1.3%1.3%2023: 2.2%2.2%2024: 1.5%1.5%2025: 2.0%2.0%202122232425
PPE ÷ total assets1.6%
2020: 2.7%2.7%2021: 2.8%2.8%2022: 0.7%0.7%2023: 1.4%1.4%2024: 1.2%1.2%2025: 1.6%1.6%202122232425

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥545.8M
2020: ¥491M¥491M2021: ¥553.9M¥553.9M2022: ¥479.9M¥479.9M2023: ¥457.5M¥457.5M2024: ¥377.3M¥377.3M2025: ¥545.8M¥545.8M202122232425
R&D / revenue16.2%
2020: 23.7%23.7%2021: 32.0%32.0%2022: 24.0%24.0%2023: 19.2%19.2%2024: 11.4%11.4%2025: 16.2%16.2%202122232425

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Oct 2021FY ending Oct 2022FY ending Oct 2023FY ending Oct 2024FY ending Oct 2025
Revenue1,7311,9972,3833,3013,360
Cost of revenue8641,0451,0261,4011,516
Gross profit8679521,3571,9001,844
SG&A1,7481,5401,6011,6431,798
Operating income-882-588-24425746
Pretax income-866-603-25829774
Income tax-686542-4152
Net income attributable to owners-793-668-300301-78
Operating margin-50.9%-29.5%-10.3%7.8%1.4%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 61%
2%
7%
Investment securities 11%
Other assets 19%

Funding

Other liabilities 13%
Equity 87%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Oct 2021FY ending Oct 2022FY ending Oct 2023FY ending Oct 2024FY ending Oct 2025
Cash and equivalents¥3.39B¥3.06B¥2.71B¥2.94B¥2.53B
Total assets¥4.55B¥3.86B¥3.71B¥4.26B¥4.15B
Net assets¥4.15B¥3.4B¥3.15B¥3.64B¥3.62B
Share capital¥1.78B¥1.78B¥1.78B¥1.86B¥1.86B
Property, plant and equipment¥126M¥25.5M¥52.5M¥49.2M¥66.3M
Intangible assets excluding goodwill¥45M—¥12.5M¥154.8M¥296.7M
Investment securities¥166.3M¥192.7M¥266.8M¥316.2M¥477.7M
Current assets¥4.08B¥3.59B¥3.33B¥3.69B¥3.25B
Current liabilities¥362.4M¥452.6M¥509M¥608.7M¥467.7M
Total liabilities¥400.5M¥460.6M¥558.6M¥621.8M¥526.4M
Equity attributable to owners of parent¥4.15B¥3.33B¥3.03B¥3.49B¥3.46B
Retained earnings¥847.3M¥189.4M-¥110.8M¥190.7M¥113.1M
Treasury stock-¥210.2M-¥371M-¥371M-¥368M-¥332.7M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第22期(2024/11/01-2025/10/31)

    ID S100XHZH2026-01-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(2023/11/01-2024/10/31)

    ID S100V5YS2025-01-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第20期(2022/11/01-2023/10/31)

    ID S100SPDF2024-01-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第19期(2021/11/01-2022/10/31)

    ID S100Q1DP2023-01-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第18期(令和2年11月1日-令和3年10月31日)

    ID S100NAE12022-01-31Open
  • EDINET (FSA Japan)

    有価証券報告書-第17期(令和1年11月1日-令和2年10月31日)

    ID S100KLSW2021-01-29Open

Extracted from XBRL: 43 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.